報價延遲最少15分鐘:2025/02/12 13:06 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
17.01 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.63/--
|
|
企業價值
158.61M
|
| 資產負債 |
|
每股賬面淨值
-0.38
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/12 13:06 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath isto enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions. |